Udvalget for Humanmedicinske Lægemidler (CHMP) noterede sig, at Firmagon var lige så effektivt som leuprorelin i hovedundersøgelsen.
The Committee for Medicinal Products for Human Use (CHMP) noted that Firmagon was as effective as leuprorelin in the main study.